The World Health Organization (WHO) established the Technical Advisory Group on Diabetes (TAG-D) in August 2021 to act as an advisory body to WHO to further WHO’s leadership and coordination role in promoting and monitoring global action against diabetes.
TAG-D normally meets twice per year to provide technical advice to WHO on matters relating to WHO’s work on diabetes. In its capacity as an advisory body to WHO, the TAG-D have the following functions:
- to identify and describe current and future challenges;
- to advise WHO on strategic directions to be prioritized;
- to advise WHO on the development of global strategic documents; and
- to propose other strategic interventions and activities for implementation by WHO.
WHO has recently appointed a new expert to replace a departing member of TAG-D. The name and bio of the expert (“published information”) is disclosed for public notice and comment.
The published information is provided by the experts themselves and is the sole responsibility of the individuals concerned. WHO is not responsible for the accuracy, veracity and completeness of the published information provided. Furthermore, in no event will WHO be responsible or liable for damages in relation to the use of, and reliance upon, the published information.
The comments received by WHO through the public notice and comment process are treated confidentially and their receipt will be acknowledged through a generic email notification to the sender. Comments and perceptions brought to the knowledge of WHO through this process are an integral component of WHO’s conflict of interest assessment policy and are carefully reviewed. WHO reserves the right to discuss information received through this process with the relevant expert with no attribution to the provider of such information. Upon review and assessment of the information received through this process, WHO, in its sole discretion, may take appropriate management action in accordance with its policies.
The participation of an expert in a WHO meeting does not imply that they are endorsed or recommended by the World Health Organization, nor does it create a binding relationship between the expert and WHO.
Submitting public comments
Comments should be provided by email, and the receipt of these will be acknowledged through generic email notification to the sender.
Please send your comment to NCDDepartment@who.int with the subject, “Comments on the Technical Advisory Group on Diabetes”, indicating the name, nature and contact details of the sender.
The deadline for public comments is 30 August 2024.